COVID19 in hematological patients and telemedicine: lessons learned across Europe and the US
- 5 July 2022
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Infectious Diseases
- Vol. 35 (4) , 295-301
Abstract
Purpose of review: To describe the state-of-the-art of telemedicine in hematology through the description of most relevant studies published in the pre-COVID19 and during the COVID19 era. Recent findings: Telemedicine has recently gained momentum in hematology due to the COVID19 pandemic. Due to a necessary improvement of domiciliary follow-up of patients during the pandemic and an increase in technologies able to offer telemedicine, the number of studies has increased in the last 2 years. Telemedicine showed the potential to improve the monitoring of both benign and malignant hematological diseases. Patients affected by thalassemias, hemophilias and/or myeloproliferative diseases were monitored successfully with telemedicine platform. For higher-risk patients such as high-dose chemotherapy or stem cell transplantation, better platforms are needed (e.g. use of wearable devices systems). Also, telemedicine showed to be useful for the follow-up of hematological patients with COVID19. Summary: Despite the clear potential advantages of telemedicine for the follow-up of hematological patients, more evidence is required before adopting this approach in larger cohorts of patients. Larger- and higher-quality studies are highly needed in this setting.Keywords
This publication has 24 references indexed in Scilit:
- Following-up allogeneic transplantation recipients during the COVID-19 pandemicThe Lancet Haematology, 2020
- Rapid implementation of a COVID-19 remote patient monitoring programJournal of the American Medical Informatics Association, 2020
- Feasibility and Acceptability of Using a Telehealth Platform to Monitor Cardiovascular Risk Factors in Hematopoietic Cell Transplantation Survivors at Risk for Cardiovascular DiseaseTransplantation and Cellular Therapy, 2020
- Pilot Study of Telehealth Evaluations in Patients Undergoing Hematopoietic Cell TransplantationTransplantation and Cellular Therapy, 2020
- Characteristics of Digital Health Studies Registered in ClinicalTrials.govJAMA Internal Medicine, 2019
- An online randomized controlled trial, with or without problem-solving treatment, for long-term cancer survivors after hematopoietic cell transplantationJournal of Cancer Survivorship, 2018
- Evaluating barriers to adopting telemedicine worldwide: A systematic reviewJournal of Telemedicine and Telecare, 2016
- Early Versus Delayed Initiation of Concurrent Palliative Oncology Care: Patient Outcomes in the ENABLE III Randomized Controlled TrialJournal of Clinical Oncology, 2015
- Therapeutic alliance in telephone-administered cognitive–behavioral therapy for hematopoietic stem cell transplant survivors.Journal of Consulting and Clinical Psychology, 2012
- Development and implementation of an Internet-based survivorship care program for cancer survivors treated with hematopoietic stem cell transplantationJournal of Cancer Survivorship, 2011